Tarbox Family Office’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-1,052
Closed -$28K 616
2018
Q2
$28K Sell
1,052
-1,000
-49% -$23.5K 0.01% 191
2018
Q1
$42K Hold
2,052
0.02% 165
2017
Q4
$37K Hold
2,052
0.01% 180
2017
Q3
$46K Hold
2,052
0.02% 161
2017
Q2
$50K Hold
2,052
0.02% 147
2017
Q1
$39K Hold
2,052
0.02% 149
2016
Q4
$40K Hold
2,052
0.02% 123
2016
Q3
$32K Hold
2,052
0.02% 130
2016
Q2
$29K Hold
2,052
0.02% 137
2016
Q1
$35K Hold
2,052
0.03% 128
2015
Q4
$46K Buy
+2,052
New +$42.3K 0.04% 98
2015
Q1
Sell
-19,522
Closed -$390K 554
2014
Q4
$390K Sell
19,522
-6,000
-24% -$103K 0.36% 32
2014
Q3
$376K Hold
25,522
0.34% 39
2014
Q2
$469K Hold
25,522
0.42% 33
2014
Q1
$491K Buy
+25,522
New +$523K 0.44% 31

Other funds holding ATRC

Tarbox Family Office's ATRC Position: Q3 2018 in Review

Tarbox Family Office sold out of AtriCure (ATRC) in Q3 2018, closing a stake of 1,052 shares — an estimated $28K sold.

Tarbox Family Office first reported a position in ATRC in Q1 2014 and held it in 15 quarters. The position peaked at $491K in Q1 2014. 126 funds tracked by Wall St. Rank hold ATRC as of Q3 2018.

  • Tarbox Family Office reported no remaining AtriCure position as of Q3 2018 after selling out during the quarter.
  • Tarbox Family Office sold 1,052 AtriCure shares in Q3 2018, an estimated $28K.
  • Tarbox Family Office first reported a position in AtriCure in Q1 2014 and held it in 15 quarters.
  • Tarbox Family Office's AtriCure position peaked at $491K in Q1 2014.
  • 126 funds tracked by Wall St. Rank held AtriCure as of Q3 2018.

Based on Tarbox Family Office's 13F filing for Q3 2018, filed 29 Oct 2018.